169 related articles for article (PubMed ID: 18059183)
1. hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.
Shen Y; Zhang YW; Zhang ZX; Miao ZH; Ding J
Cancer Biol Ther; 2008 Feb; 7(2):228-36. PubMed ID: 18059183
[TBL] [Abstract][Full Text] [Related]
2. Silencing of the hTERT gene by shRNA inhibits colon cancer SW480 cell growth in vitro and in vivo.
Liu AQ; Ge LY; Lu XL; Luo XL; Cai YL; Ye XQ; Geng FF
PLoS One; 2014; 9(9):e107019. PubMed ID: 25207650
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
Shi YA; Zhao Q; Zhang LH; Du W; Wang XY; He X; Wu S; Li YL
Int J Oncol; 2014 Sep; 45(3):1216-24. PubMed ID: 24920549
[TBL] [Abstract][Full Text] [Related]
4. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
Kurvinen K; Syrjänen S; Johansson B
Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
7. siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells.
Hao H; Nancai Y; Lei F; Xiong W; Wen S; Guofu H; Yanxia W; Hanju H; Qian L; Hong X
J Exp Clin Cancer Res; 2008 Aug; 27(1):27. PubMed ID: 18694522
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines.
George J; Banik NL; Ray SK
Int J Biochem Cell Biol; 2010 Jul; 42(7):1164-73. PubMed ID: 20394835
[TBL] [Abstract][Full Text] [Related]
9. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
Cheng W; Wei Z; Gao J; Zhang Z; Ge J; Jing K; Xu F; Xie P
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):391-6. PubMed ID: 20556588
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of telomerase activity in human promyelocytic cell line using RNA interference.
Miri-Moghaddam E; Deezagi A; Soheili ZS
Ann Hematol; 2009 Dec; 88(12):1169-76. PubMed ID: 19415276
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of malignant phenotype of HeLa cells by RNA interference of the telomerase activity].
Shi YA; Zhao Q; Zhang LH; Wang GL; Yu XX; Li YL; Wu S
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):187-91. PubMed ID: 20450767
[TBL] [Abstract][Full Text] [Related]
13. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Luo Y; Yi Y; Yao Z
Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
[TBL] [Abstract][Full Text] [Related]
14. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
15. Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo.
Xie M; Chen Q; He S; Li B; Hu C
Oncol Rep; 2011 Oct; 26(4):1019-27. PubMed ID: 21743972
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
de Souza Nascimento P; Alves G; Fiedler W
Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
[TBL] [Abstract][Full Text] [Related]
17. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
[TBL] [Abstract][Full Text] [Related]
18. hTERT-siRNA could potentiate the cytotoxic effect of gemcitabine to pancreatic cancer cells Bxpc-3.
Tan J; Zhou X; Zhu H
Exp Clin Transplant; 2012 Aug; 10(4):386-93. PubMed ID: 22757972
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of human telomerase reverse transcriptase through anti-C-myc siRNA in human colon cancer Colo 320 cells.
Hu X; Yu N; Fu L; Su W; Huang G; Wu Y; Huang H; Huang H
Nucleosides Nucleotides Nucleic Acids; 2009; 28(1):1-11. PubMed ID: 19116866
[TBL] [Abstract][Full Text] [Related]
20. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
